Drug
4D 150 Ivt
4D 150 Ivt: highest development phase Phase 3, developed by 4D Molecular Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- 4D Molecular Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| 4D-150 IVT (3x10^10 vg) NCT07867080 | Phase 3 | Diabetic Macular Edema (DME) |
Latest
No recent events.
Follow 4D 150 Ivt on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.